IL6 and bone cancer: The results showed that intrathecal injection of miR-9-5p modified BM-MSCs could reduce the expression of REST and increase the expression of MOR, inhibit the release of inflammatory factors TNF-α, IL-6, and IL-1β in the spinal cord dorsal horn of mice, and relieve bone cancer pain [12].